Evidence map›Paper›PMID 25232744›Full record

ArticleNature communications2014

De novo TBR1 mutations in sporadic autism disrupt protein functions.

Pelagia Deriziotis, Brian J O'Roak, Sarah A Graham, Sara B Estruch, Danai Dimitropoulou, Raphael A Bernier, Jennifer Gerdts, Jay Shendure, Evan E Eichler, Simon E Fisher

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. NovelGenes · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Shared and Distinct Functional Effects of Patient-SpecificThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Pelagia DeriziotisLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen 6525XD, The Netherlands.
Brian J O'Roak1] Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington 98195, USA [2] Department of Molecular and Medical Genetics, Oregon Health &Science University, Portland, Oregon 97239, USA.
Sarah A GrahamLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen 6525XD, The Netherlands.
Sara B EstruchLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen 6525XD, The Netherlands.
Danai DimitropoulouLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen 6525XD, The Netherlands.
Raphael A BernierDepartment of Psychiatry and Behavioural Sciences, University of Washington, Seattle, Washington 98195, USA.
Jennifer GerdtsDepartment of Psychiatry and Behavioural Sciences, University of Washington, Seattle, Washington 98195, USA.
Jay ShendureDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, Washington 98195, USA.
Evan E Eichler1] Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington 98195, USA [2] Howard Hughes Medical Institute, Seattle, Washington 98195, USA.
Simon E Fisher1] Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen 6525XD, The Netherlands [2] Donders Institute for Brain, Cognition and Behaviour, Nijmegen 6525EN, The Netherlands.
University of Washington · USMax Planck Institute for Psycholinguistics · NLRadboud University Nijmegen · NL

Funding

Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
Howard Hughes Medical InstituteNICHD NIH HHS U54 HD083091NIMH NIH HHS MH101221NIMH NIH HHS R01 MH101221
6 · The paper itself

Abstract

Next-generation sequencing recently revealed that recurrent disruptive mutations in a few genes may account for 1% of sporadic autism cases. Coupling these novel genetic data to empirical assays of protein function can illuminate crucial molecular networks. Here we demonstrate the power of the approach, performing the first functional analyses of TBR1 variants identified in sporadic autism. De novo truncating and missense mutations disrupt multiple aspects of TBR1 function, including subcellular localization, interactions with co-regulators and transcriptional repression. Missense mutations inherited from unaffected parents did not disturb function in our assays. We show that TBR1 homodimerizes, that it interacts with FOXP2, a transcription factor implicated in speech/language disorders, and that this interaction is disrupted by pathogenic mutations affecting either protein. These findings support the hypothesis that de novo mutations in sporadic autism have severe functional consequences. Moreover, they uncover neurogenetic mechanisms that bridge different neurodevelopmental disorders involving language deficits.

Indexed as

MutationAmino Acid SequenceAutism Spectrum DisorderCell Line, TumorChildChild, PreschoolDimerizationFemaleForkhead Transcription FactorsHEK293 CellsHigh-Throughput Nucleotide SequencingHumansLanguage DisordersMaleMolecular Sequence DataMutagenesis, Site-DirectedForkhead Transcription FactorsFOXP2 protein, humanT-Box Domain ProteinsTBR1 protein, human

Identifiers

PMID25232744
PMCPMC4212638
OpenAlexW2155963584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.